Pantothenate kinase-associated neurodegeneration: Clinical aspects, diagnosis and treatments
Pantothenate Kinase-Associated Neurodegeneration (PKAN) is an autosomal recessive disorder characterized by a mutation in the PANK2 gene. The clinical presentation may range from only speech disorder to severe generalized dystonia, spasticity, Visual loss, dysphagia and dementia. The hallmark of thi...
Saved in:
Main Authors: | Saeed Razmeh (Author), Amir Hassan Habibi (Author), Maryam Orooji (Author), Elham Alizadeh (Author), Karim Moradiankokhdan (Author), Behroz Razmeh (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pilot trial of deferiprone in pantothenate kinase-associated neurodegeneration patients
by: Mohammad Rohani, et al.
Published: (2018) -
A novel homozygous variation in the PANK2 gene in two Persian siblings with atypical pantothenate kinase associated neurodegeneration
by: Amir Hasan Habibi, et al.
Published: (2019) -
Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
by: Mónica Álvarez-Córdoba, et al.
Published: (2023) -
Treatment of Levodopa-induced dyskinesia with Vitamin D: A Randomized, double-blind, placebo-controlled trial
by: Amir Hassan Habibi, et al.
Published: (2018) -
Stiff person case misdiagnosed as conversion disorder: A case report
by: Saeed Razmeh, et al.
Published: (2017)